NovaPoint Capital’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
63,431
+3,274
+5% +$71.4K 0.29% 74
2026
Q1
$1.32M Buy
60,157
+1,110
+2% +$24.5K 0.33% 71
2025
Q4
$1.3M Buy
59,047
+7,271
+14% +$161K 0.34% 68
2025
Q3
$1.15M Buy
51,776
+3,509
+7% +$77.2K 0.28% 74
2025
Q2
$1.06M Sell
48,267
-620
-1% -$13.4K 0.33% 65
2025
Q1
$1.06M Buy
48,887
+891
+2% +$19.1K 0.33% 68
2024
Q4
$1.03M Buy
47,996
+2,775
+6% +$60K 0.31% 66
2024
Q3
$1M Buy
45,221
+6,068
+15% +$132K 0.31% 69
2024
Q2
$832K Buy
+39,153
New +$827K 0.28% 71

Other funds holding IBDV

NovaPoint Capital's IBDV Position: Q2 2026 in Review

NovaPoint Capital increased its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 5.4% in Q2 2026, buying an estimated $71.4K and bringing the position to 63,431 shares worth $1.38M. The position accounts for 0.29% of the portfolio, ranked #74.

NovaPoint Capital first reported a position in IBDV in Q2 2024 and has held it in 9 quarters since. 349 funds tracked by Wall St. Rank hold IBDV as of Q2 2026.

  • NovaPoint Capital held 63,431 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $1.38M as of Q2 2026.
  • NovaPoint Capital bought 3,274 iShares iBonds Dec 2030 Term Corporate ETF shares in Q2 2026, an estimated $71.4K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 0.29% of NovaPoint Capital's portfolio in Q2 2026, its #74 holding.
  • NovaPoint Capital first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q2 2024 and has held it in 9 quarters since.
  • 349 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.